ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response (Q36043008)

11 August 2017

ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1979.95

11 August 2017

1 reference

7 June 2023

author name string

C. J. Kovacs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486307

5 July 2022

M. J. Evans

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486307

5 July 2022

L. L. Schenken

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486307

5 July 2022

D. R. Burholt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486307

5 July 2022

language of work or name

English

0 references

publication date

1 May 1979

1 reference

PMC publication ID

2009898

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC2009898

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486307

https://europepmc.org/articles/PMC2009898?pdf=render

5 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A486307

http://www.nature.com/articles/bjc197995.pdf

5 July 2022

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1979.95

http://www.nature.com/articles/bjc197995

7 June 2023

1 reference

https://api.crossref.org/works/10.1038/BJC.1979.95

British Journal of Cancer

7 June 2023

published in

1 reference

11 August 2017

39

1 reference

11 August 2017

5

1 reference

11 August 2017

516-523

1 reference

Proceedings: Mechanism of action studies with IRCF 159: effects on the growth and morphology of BHK-21S cells

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

A Comparative Study of the Response to Radiation by Experimental Tumors with Markedly Different Growth Characteristics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour line

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Interaction of ICRF 159 with radiation, and its effect on sub-lethal and potentially lethal radiation damage in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Cell Proliferation and the Action of Cytotoxic Agents on Haemopoietic Tissue

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2009898

Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors

23 September 2018

1 reference

12 December 2020

The effect of (±) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma

1 reference

12 December 2020

Cell population kinetics of transplanted and metastatic Lewis lung carcinoma

1 reference

12 December 2020

Cumulative Cytostatic Effect of ICRF 159

1 reference

12 December 2020

The relationship between the ‘cell loss factor’ and the immediate response to radiation in animal tumours

1 reference

12 December 2020

Modification of the radiocurability of a syngeneic murine squamous carcinoma by its site of growth, by electron-affinic drugs, and by ICRF 159

1 reference

12 December 2020

Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic

1 reference

12 December 2020

Mode of Action of the Cytostatic Agent ‘ICRF 159’

1 reference

12 December 2020

Control of Malignant Metastases by ICRF 159

1 reference

12 December 2020

Effect of ICRF159 on the mammalian cell cycle: significance for its use in cancer chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1979.95

1 reference

11 August 2017

1 reference

PMC publication ID

2009898

11 August 2017

1 reference

PMC publication ID

2009898